Smith & Nephew logo
Smith & Nephew
SNN | NYSE
Chart Builder DCF Calculator
$30.97
-$0.31 (-0.99%)
At close: Nov 16, 2026, 4:00 PM ET
$30.97
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:55 PM ET

Smith & Nephew Company Profile

Company profile explained

Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. The company also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it provides arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Key Executives

Name Position
Deepak S. Nath Chief Executive Officer & Director
John Terence Rogers Chief Financial Officer
Ajay Dhankhar Chief Corporate Development & Strategy Officer
Alison Parkes Chief Compliance Officer & Compliance APAC
Charles Reynolds Head of Corporate Communication
Elga Lohler Chief Human Resources Officer
Emily Heaven Head of Investor Relations
Helen Barraclough Group General Counsel & Company Secretary
Paul Connolly President of Global Operations
Pierre Palassian Interim CFO, Senior VP of Finance & Group Controller
Steve Kane Head of Human Resources for the US, Global Marketing and Global R&D
Vasant Padmanabhan President Research & Development, ENT and Emerging Markets

Latest SEC Filings

Date Type Title
Oct 22, 2026 6-K Filing
Oct 09, 2026 S-8 Filing
Oct 08, 2026 6-K Filing
Oct 05, 2026 25-NSE Filing
Oct 01, 2026 6-K Filing
Oct 01, 2026 6-K Filing
Sep 18, 2026 6-K Filing
Sep 18, 2026 6-K Filing
Sep 17, 2026 CERT Filing
Sep 16, 2026 6-K Filing
View All SEC Filings ➞
Smith & Nephew
Smith & Nephew logo
Country United Kingdom
IPO Date Nov 16, 1999
Industry Medical - Devices
Sector Healthcare
Employees 18,362
CEO Deepak S. Nath

Contact Details

Building 5 Croxley Park Hatters Lane Watford, HRT WD18 8YE United Kingdom

Stock Details

Ticker Symbol SNN
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000845982
CUSIP Number 83175M205
ISIN Number US83175M2052
SIC Code 3842

Recent News

More News ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.